The frequency of sacroiliitis in familial Mediterranean fever and the role of HLA-B27 and MEFV mutations in the development of sacroiliitis T Kaşifoğlu, C Çalışır, DÜ Cansu, C Korkmaz Clinical rheumatology 28, 41-46, 2009 | 120 | 2009 |
Short-term course of chronic hepatitis B and C under treatment with etanercept associated with different disease modifying antirheumatic drugs without antiviral prophylaxis. DU Cansu, T Kalifoglu, C Korkmaz The Journal of rheumatology 35 (3), 421-424, 2008 | 104 | 2008 |
Myocardial infarction in young patients (≤ 35 years of age) with systemic lupus erythematosus: a case report and clinical analysis of the literature C Korkmaz, DU Cansu, T Kaşifoğlu Lupus 16 (4), 289-297, 2007 | 81 | 2007 |
Hypoglycaemia induced by hydroxychloroquine in a non-diabetic patient treated for RA DÜ Cansu, C Korkmaz Rheumatology 47 (3), 378-379, 2008 | 77 | 2008 |
Frequency of abdominal surgery in patients with familial Mediterranean fever T Kasifoglu, DÜ Cansu, C Korkmaz Internal Medicine 48 (7), 523-526, 2009 | 65 | 2009 |
Predictors of radiographic severity and functional disability in Turkish patients with ankylosing spondylitis DÜ Cansu, C Çalışır, U Savaş Yavaş, T Kaşifoğlu, C Korkmaz Clinical rheumatology 30, 557-562, 2011 | 63 | 2011 |
COVID‐19 vaccination in autoimmune diseases (COVAD) study: vaccine safety in idiopathic inflammatory myopathies A Gil‐Vila, N Ravichandran, A Selva‐O'Callaghan, P Sen, A Nune, ... Muscle & nerve 66 (4), 426-437, 2022 | 35 | 2022 |
The role of MEFV mutations in the concurrent disorders observed in patients with familial Mediterranean fever S Güncan, NŞY Bilge, DÜ Cansu, T Kaşifoğlu, C Korkmaz European journal of rheumatology 3 (3), 118, 2016 | 28 | 2016 |
Serum thrombopoietin levels and its relationship with thrombocytopenia in patients with cirrhosis T Temel, DU Cansu, HE Temel, AH Ozakyol Hepatitis Monthly 14 (5), 2014 | 28 | 2014 |
How should we manage low-dose methotrexate-induced pancytopenia in patients with rheumatoid arthritis? DÜ Cansu, HÜ Teke, E Bodakçi, C Korkmaz Clinical Rheumatology 37, 3419-3425, 2018 | 26 | 2018 |
Can we predict thrombotic tendency in rheumatoid arthritis? A thromboelastographic analysis (with ROTEM) SM Türk, DÜ Cansu, HÜ Teke, T Kaşifoğlu, O Meltem Akay, M Bilgin, ... Clinical rheumatology 37, 2341-2349, 2018 | 23 | 2018 |
Clinical significance of serum IL-6, TNF-α, Hepcidin, and EPO levels in anaemia of chronic disease and iron deficiency anaemia: The laboratory indicators for anaemia HU Teke, DU Cansu, P Yildiz, G Temiz, C Bal Biomed Res 28 (6), 2704-10, 2017 | 23 | 2017 |
Regulatory T cells in Behçet’s disease: Is there a correlation with disease activity? Does regulatory T cell type matter? E Gündüz, HÜ Teke, NŞY Bilge, DÜ Cansu, C Bal, C Korkmaz, Z Gülbaş Rheumatology international 33, 3049-3054, 2013 | 22 | 2013 |
COVID-19 vaccination in autoimmune diseases (COVAD) study: vaccine safety and tolerance in rheumatoid arthritis R Naveen, I Parodis, M Joshi, P Sen, J Lindblom, V Agarwal, JB Lilleker, ... Rheumatology 62 (7), 2366-2376, 2023 | 19 | 2023 |
Urolithiasis as an extraarticular manifestation of ankylosing spondylitis C Korkmaz, DÜ Cansu, JA Sayer Rheumatology international 37, 1949-1956, 2017 | 19 | 2017 |
Do clinical findings of Behçet’s disease vary by gender?: A single-center experience from 329 patients DÜ Cansu, T Kaşifoğlu, C Korkmaz European journal of rheumatology 3 (4), 157, 2016 | 19 | 2016 |
Disease-modifying antirheumatic drugs increase serum adiponectin levels in patients with rheumatoid arthritis B Cansu, DU Cansu, T Kasifoglu, Z Gülbas, C Korkmaz JCR: Journal of Clinical Rheumatology 17 (1), 14-17, 2011 | 19 | 2011 |
Combined thrombophilic factors increase the risk of recurrent thrombotic events in Behcet’s disease NŞ Yaşar, F Salgür, DÜ Cansu, T Kaşifoğlu, C Korkmaz Clinical rheumatology 29, 1367-1372, 2010 | 19 | 2010 |
Pulmonary hypertension in connective tissue diseases: epidemiology, pathogenesis, and treatment DÜ Cansu, C Korkmaz Clinical Rheumatology 42 (10), 2601-2610, 2023 | 18 | 2023 |
Lymphopenia as a risk factor for neurologic involvement and organ damage accrual in patients with systemic lupus erythematosus: a multi-center observational study S Yavuz, DU Cansu, D Nikolopoulos, F Crisafulli, AM Antunes, ... Seminars in arthritis and rheumatism 50 (6), 1387-1393, 2020 | 18 | 2020 |